The transplant, part of a three-person compassionate use study, used a pig kidney with 69 gene edits provided by US-based biotech eGenesis. The company received the go-ahead from the US Food and ...

The MGH clinical team also performed the historic first transplant of a genetically engineered porcine kidney, supplied by eGenesis, into a living human in March 2024. The recipient, 66-year-old ...

On a 300-acre farm in an undisclosed location in rural Wisconsin, surrounded by fields dotted with big red barns and bordered ...

The US FDA has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.

David-Alexandre C. Gros, MD, CEO of Eledon Pharmaceuticals, is overjoyed to learn that the second patient to receive a genetically modified pig kidney developed by eGenesis has been released from ...

BioAge plans to list on the Nasdaq under the symbol BIOA. Topping the list of recent private rounds is eGenesis, a developer of transplant organs from pigs designed to be compatible with humans ...

The biotech company United Therapeutics plans to include up to 50 people in the study this summer; the second company involved is eGenesis.

The original genetically modified pig was produced by U.S. biotechnology company eGenesis. In September 2023, PorMedTec received cells from the pig and produced cloned fertilized eggs.

The MGH clinical team also performed the historic first transplant of a genetically engineered porcine kidney, supplied by eGenesis, into a living human in March 2024. The recipient, 66-year-old Tim ...